Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.88
+0.32 (3.74%)
At close: Jun 26, 2026, 4:00 PM EDT
8.90
+0.02 (0.23%)
Pre-market: Jun 29, 2026, 9:10 AM EDT
Novavax Employees
Novavax had 749 employees as of December 31, 2025. The number of employees decreased by 203 or -21.32% compared to the previous year.
Employees
749
Change (1Y)
-203
Growth (1Y)
-21.32%
Revenue / Employee
$796,179
Profits / Employee
-$117,270
Market Cap
1.46B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 767 |
| Immunocore Holdings | 524 |
| Ardelyx | 489 |
| Capricor Therapeutics | 231 |
| Maze Therapeutics | 141 |
| MapLight Therapeutics | 133 |
| Inhibrx Biosciences | 110 |
| Savara | 70 |
NVAX News
- 5 days ago - Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM - GlobeNewsWire
- 11 days ago - Novavax Transcript: AGM 2026 - Transcripts
- 24 days ago - Novavax Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 27 days ago - Novavax to Participate in 2026 Jefferies Global Healthcare Conference - PRNewsWire
- 6 weeks ago - Novavax Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Novavax Slides: Corporate presentation - Filings
- 7 weeks ago - Hantavirus cases spark surge in pharma and biotech stocks — here's why - CNBC
- 7 weeks ago - Novavax to Participate in BofA Securities 2026 Health Care Conference - PRNewsWire